The Next Longevity Roll-Up May Not Be Biotech – It May Be Clinics, Labs, and Data
Argue that consolidation may happen first in care delivery and diagnostics infrastructure rather than pure therapeutics. The piece keeps the focus on evidence, commercial logic, and what would make the claim testable.









